Overview

Study Of Sunitinib With Capecitabine In Breast Cancer

Status:
Completed
Trial end date:
2012-05-01
Target enrollment:
Participant gender:
Summary
To evaluate efficacy, safety and pharmacokinetics of sunitinib plus Capecitabine in Japanese patients with advanced/metastatic breast cancer.
Phase:
Phase 2
Details
Lead Sponsor:
Pfizer
Treatments:
Capecitabine
Sunitinib